7M5Z
Crystal Structure of the MerTK Kinase Domain in Complex with Inhibitor MIPS15692
Summary for 7M5Z
Entry DOI | 10.2210/pdb7m5z/pdb |
Descriptor | Tyrosine-protein kinase Mer, 2-(butylamino)-N-[1-(3-fluoropropyl)piperidin-4-yl]-4-{[(1r,4r)-4-hydroxycyclohexyl]amino}pyrimidine-5-carboxamide (3 entities in total) |
Functional Keywords | kinase, signaling protein-inhibitor complex, signaling protein/inhibitor |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 2 |
Total formula weight | 72904.16 |
Authors | Hermans, S.J.,Hancock, N.C.,Baell, J.B.,Parker, M.W. (deposition date: 2021-03-25, release date: 2021-10-06, Last modification date: 2023-10-18) |
Primary citation | Wong, S.W.,Vivash, L.,Mudududdla, R.,Nguyen, N.,Hermans, S.J.,Shackleford, D.M.,Field, J.,Xue, L.,Aprico, A.,Hancock, N.C.,Haskali, M.,Stashko, M.A.,Frye, S.V.,Wang, X.,Binder, M.D.,Ackermann, U.,Parker, M.W.,Kilpatrick, T.J.,Baell, J.B. Development of [ 18 F]MIPS15692, a radiotracer with in vitro proof-of-concept for the imaging of MER tyrosine kinase (MERTK) in neuroinflammatory disease. Eur.J.Med.Chem., 226:113822-113822, 2021 Cited by PubMed: 34563964DOI: 10.1016/j.ejmech.2021.113822 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (3.06 Å) |
Structure validation
Download full validation report